Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis

S Kumar1, S M Blake, J G Emery

  • 1Musculoskeletal Diseases, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA 19406-0939, USA. sanjay_kumar-1@gsk.com

Insights

Rheumatoid arthritis treatments may target key inflammatory pathways. Understanding interleukin-1 and tumor necrosis factor alpha signaling offers new therapeutic opportunities.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) pathogenesis involves complex cellular and molecular mechanisms.
  • Interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-α) are critical inflammatory cytokines in RA.
  • Targeting these cytokines presents a significant therapeutic challenge.

Purpose of the Study:

  • To identify and characterize intracellular signaling pathways linked to IL-1 and TNF-α in RA.
  • To explore potential therapeutic targets within these pathways.
  • To understand the cross-talk between key signaling cascades.

Main Methods:

  • Analysis of cellular and molecular mechanisms in rheumatoid arthritis.
  • Identification and characterization of intracellular signaling pathways.
  • Focus on mitogen-activated protein kinase (MAPK) and nuclear factor kappaB (NF-κB) pathways.

Main Results:

  • IL-1 and TNF-α play crucial roles in RA.
  • Specific intracellular signaling pathways, including MAPK and NF-κB, are associated with these cytokines.
  • Cross-talk between MAPK and NF-κB pathways identified.

Conclusions:

  • The identified signaling pathways represent potential therapeutic targets for RA.
  • Targeting intracellular signaling offers a promising strategy for RA treatment.
  • Further research into pathway modulation could lead to novel RA therapies.

Related Concept Videos

Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...